The epidemiology of hepatitis C in Australia: Notifications, treatment uptake and liver transplantations, 1997-2006

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 10, 2009, Pages 1648-1654

  Gidding, Heather F ^a   Topp, Libby ^c   Middleton, Melanie ^a   Robinson, Kate ^e   Hellard, Margaret ^f   McCaughan, Geoffrey ^d   Maher, Lisa ^a,b   Kaldor, John M ^a   Dore, Gregory J ^a   Law, Matthew G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Justice Health Centre for Health Research in Criminal Justice   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e Surveillance Branch Office of Health Protection Department of Health and Ageing ^*  (Australia)

^f BURNET INSTITUTE   (Australia)

Author keywords

Australia; Epidemiology; Hepatitis C

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; AGED; ARTICLE; AUSTRALIA; CHRONIC DISEASE; DISEASE REGISTRY; DISEASE SURVEILLANCE; DRUG USE; FEMALE; GRAFT RECIPIENT; GROUPS BY AGE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; INFECTION RISK; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 70349667327     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05910.x     Document Type: Article

References (29)

1. Razali K, Thein H, Bell J et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend. 2007 91 : 228 235.
2. Ministerial Advisory Committee on AIDS Sexual Health and Hepatitis C Sub-Committee. Hepatitis C Virus Projections Working Group: Estimates and Projections of the Hepatitis C Virus Epidemic in Australia. Sydney : National Centre in HIV Epidemiology and Clinical Research, The University of NSW, 2006. Cited 9 Jan 2009. Available from URL: http://www.nchecr.unsw.edu.au/NCHECRweb. nsf/resources/HCVPWG2006/$file/HCVPWGRepAug06.pdf
3. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report 1997. Sydney : National Centre in HIV Epidemiology and Clinical Research, The University of NSW, 1998.
4. Longbottom H, Evans D, Htoo M, Hargreaves J. Annual Report of the National Notifiable Diseases Surveillance System, 1993. Commun. Dis. Intell. 1994 18 : 518 548.
5. Spencer J, Dore G, Robotin M et al. Outcomes from the first two years of the Australian hepatitis C surveillance strategy. Commun. Dis. Intell. 2002 26 : 14 22.
6. Communicable Diseases Network Australia. Interim Surveillance Case Definitions for the Australian National Notifiable Diseases Surveillance System. Version 1. 2004. Cited 14 Jan 2009. Available from URL: http://www.health.gov. au/internet/main/publishing.nsf/Content/cdna-casedefinitions.htm
7. Australia and New Zealand Liver Transplant Registry. Cited 9 Jan 2009. Available from URL: http://www.anzltr.org/
8. Dore GJ, Law M, MacDonald M, Kaldor JM. Epidemiology of hepatitis C virus infection in Australia. J. Clin. Virol. 2003 26 : 171 184.
9. National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hapatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report 2007. Sydney : National Centre in HIV Epidemiology and Clinical Research, The University of NSW, 2007.
10. Guy R, Devadason D, Lim M et al. Enhanced case detection for newly acquired hepatitis C infection: Epidemiological findings and health service implications. Commun. Dis. Intell. 2008 32 : 250 256.
11. Maher L, Jalaludin B, Chant KG et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 2006 101 : 1499 1508.
12. National Centre in HIV Epidemiology and Clinical Research. Australian NSP survey national data report, 2003-2007. Sydney : National Centre in HIV Epidemiology and Clinical Research, The University of NSW, 2008.
13. Day C, Degenhardt L, Gilmour S, Hall W. Effects of reduction in heroin supply on injecting drug use: Analysis of data from needle and syringe programmes. BMJ 2004 329 : 428 429.
14. Degenhardt L, Day C, Dietze P et al. Effects of a sustained heroin shortage in three Australian States. Addiction 2005 100 : 908 920.
15. Day C, Topp L, Rouen D, Darke S, Hall W, Dolan K. Decreased heroin availability in Sydney in early 2001. Addiction 2003 98 : 93 5.
16. Topp L, Day C, Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug Alcohol Depend. 2003 70 : 275 286.
17. Maher L, Li J, Jalaludin B et al. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia. Drug Alcohol Depend. 2007 89 : 244 250.
18. Weatherburn D, Jones C, Freeman K, Makkai T. Supply control and harm reduction: Lessons from the Australian heroin 'drought'. Addiction 2003 98 : 83 91.
19. Topp L, Iversen J, Wand H et al. Representativeness of injecting drug users who participate in HIV surveillance: Results from Australia's Needle and Syringe Program Survey. JAIDS 2008 47 : 632 638.
20. Day C, Degenhardt L, Hall W. Changes in the initiation of heroin use after a reduction in heroin supply. Drug Alcohol Rev. 2006 25 : 307 313.
21. Sheil AGR. Liver transplantation for hepatitis and hepatoma. Transplant. Proc. 2002 34 : 2463 2464.
22. Kim AI, Saab S. Treatment of hepatitis C. Am. J. Med. 2005 118 : 808 815.
23. Poynard T, McHutchison J, Manns M et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology. 2002 122 : 1303 1313.
24. Hallinan R, Byrne A, Dore GJ. Harm reduction, hepatitis C and opioid pharmacotherapy: An opportunity for integrated hepatitis C virus-specific harm reduction. Drug Alcohol Rev. 2007 26 : 437 443.
25. Blumer C, Roche P, Spencer J et al. Australia's notifiable disease status, 2001: Annual report of the National Notifiable Diseases Surveillance System. Commun. Dis. Intell. 2003 27 : 1 78.
26. Robotin MC, Copland J, Tallis G et al. Surveillance for newly acquired hepatitis C in Australia. J. Gastroenterol. Hepatol. 2004 19 : 283 288.
27. Centers for Disease Control and Prevention (CDC). Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users: New York, November 2004-April 2007. MMWR 2008 57 : 517 521.
28. Fischer RP, Haley RW. Biases in surveillance of hepatitis C infection systematically underestimate the etiologic role of tattooing. J. Gastroenterol. Hepatol. 2004 19 : 1222 1223.
29. Department of Human Services Victoria. Sentinel Surveillance - Blood Borne Viruses and Sexually Transmitted Infections, Hepatitis C Report: April to December 2006. Melbourne : Department of Human Services, Victoria, 2007. Cited 14 Jan 2009. Available from URL: http://www.health.vic.gov.au/ideas/ surveillance/descriptive-reports